[Cyanotic congenital heart disease. Part 1]

Masaaki Kawada1

  • 1Department of Pediatric and Congenital Cardiovascular Surgery, Jichi Children's Medical Center Tochigi, Shimotsuke, Japan.

Insights

This review covers cyanotic complex congenital heart diseases like TGA and HLHS, focusing on early-life interventions and surgical outcomes. Advances in repair techniques aim to improve long-term survival for these critical conditions.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Surgery
  • Neonatal Medicine

Context:

  • Cyanotic complex congenital heart diseases often manifest in neonates and infants.
  • Many require ductal dependency for survival, necessitating timely intervention.
  • Key conditions discussed include TGA, TAPVC, PPA/PPS, and HLHS.

Purpose:

  • To review current surgical strategies and outcomes for major cyanotic congenital heart diseases.
  • To highlight advancements in repair techniques and their impact on patient survival.
  • To discuss the challenges and future directions in managing these complex pediatric cardiac conditions.

Summary:

  • Complete transposition of the great arteries (TGA) is often managed with the Jatene procedure, with good long-term results.
  • Total anomalous pulmonary venous connection (TAPVC) repair shows good outcomes, with sutureless pericardial repair emerging to prevent complications.
  • Hypoplastic left heart syndrome (HLHS) requires a staged approach, with innovations like the right ventricle-to-pulmonary artery conduit improving results.
  • Pulmonary atresia/stenosis (PPA/PPS) management varies, with single ventricle physiology offering fair outcomes in many cases.

Impact:

  • Improved surgical techniques and staged approaches are enhancing survival rates for complex congenital heart diseases.
  • Ongoing research and innovation promise further refinements in treatment and long-term management.
  • Early diagnosis and intervention remain critical for optimizing outcomes in affected infants.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...